e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Interactions between pulmonary physiology and general medicine
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Analysis of bronchodilator response in patients with controlled asthma
T. Koga, T. Kamimura, Y. Oshita, H. Koga, H. Aizawa (Kurume, Japan)
Source:
Annual Congress 2004 - Interactions between pulmonary physiology and general medicine
Session:
Interactions between pulmonary physiology and general medicine
Session type:
Poster Discussion
Number:
1407
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Koga, T. Kamimura, Y. Oshita, H. Koga, H. Aizawa (Kurume, Japan). Analysis of bronchodilator response in patients with controlled asthma. Eur Respir J 2004; 24: Suppl. 48, 1407
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020
Evaluation of the individual bronchodilator response in patients with severe COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 246s
Year: 2002
Meta-analysis of inhaled corticosteroids response in children with asthma.
Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics
Year: 2019
Bronchodilator reversibility and short-term inhaled corticosteroid response in Japanese patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 341s
Year: 2004
Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial
Source: Eur Respir J 2007; 30: 457-466
Year: 2007
Obesity and the response to inhaled budesonide in patients with asthma
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007
Effect of long-acting ß-agonist on bronchodilator response in children with asthma
Source: Eur Respir J, 56 (3) 1902010; 10.1183/13993003.02010-2019
Year: 2020
Evaluation of bronchodilator responses in patients with advanced COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 148s
Year: 2001
Pharmacogenetics of inhaled corticosteroid response in adults with asthma
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020
Longitudinal change in bronchial responsiveness in patients with cough variant asthma and the effect of inhaled corticosteroids
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004
The bronchodilator response and clinical characteristics of patients with bronchiectasis
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
Assessment of maximal airway response before and after inhaled corticosteriod treatment in new diagnosed asthma patients
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007
CAPTAIN: Effects of triple therapy on FEV1 response in patients with inadequately controlled asthma on ICS/LABA
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021
A pooled analysis of FEV
1
decline in COPD patients randomized to inhaled corticosteroids or placebo
Source: Eur Respir J 2006; 28: Suppl. 50, 764s
Year: 2006
Acute bronchodilator response does not predict health outcomes in patients with COPD treated with tiotropium
Source: Annual Congress 2009 - Next generation bronchodilators
Year: 2009
The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 240s
Year: 2002
Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012
Inhaled corticosteroids in patients with mild to moderate COPD with and without airway hyperresponsiveness to mannitol: A randomized placebo controlled trial
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Does acute bronchodilator test is predictive of inhaled corticosteroid response in COPD/asthma patients?
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept